Invivyd Inc.
IVVD | NASDAQ
$0.58
-$0.02 (-3.65%)
At close: Oct 30, 2026, 4:00 PM ET
$0.59
+$0.01 (+1.74%)
Pre-market:
Nov 2, 2026, 7:14 AM ET
-3.65%
(1D)No price chart data available for 1D timeframe.
Rating
44.2
+1.0 ptsFundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #417/1028 (Top 41%)
Key Statistics
Market Data
Market Cap $171.46M
1D Range
0.54 0.59
52W Range
0.54 2.88
Valuation (TTM)
PE -1.49
PB 0.95
EV/EBITDA -0.18
Valuation (NTM)
Forward PE 13.71
Forward PEG -0.04
Price Target $9.50
Cash Flow
FCF Yield -64.0%
SBC Adj. FCF Yield -70.5%
SBC Impact -10.2%
Margins
Gross Margin 91.3%
Operating Margin -192.8%
FCF Margin -187.9%
Growth (CAGR)
Revenue 3Y | 5Y 78.8% |
76.3%
Dil EPS 3Y | 5Y 68.3% |
47.2%
FCF 3Y | 5Y 28.2% |
20.3%
Returns
ROA -49.0%
ROE -59.7%
ROIC -59.4%
Financial Health
Net Cash
$160.08M
Current Ratio 5.87
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived ...
Sector Healthcare
Industry Biotechnology
Employees 122
IPO Date Aug 6, 2021
Website www.invivyd.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
4
Consensus
Buy
Price Target
$9.50
Upside
+1537.93%
Buy (3)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove IVVD